Juvenile spondyloarthritis (jSpA) is a complex disease with both genetic and environmental factors contributing to etiology. Multiple studies have shown that epigenetic mechanisms could link the environment and gene expression and thus provide a potential explanation for external contribution in the pathogenesis of numerous diseases, including rheumatic. Previously obtained gene signatures in jSpA patients revealed distinctive expression of important immune-related genes, though the mechanism(s) responsible for those alterations remained unknown. The purpose of this study was to evaluate the methylation levels of the TLR4, CXCR4, NLRP3, and PTPN12 gene promoter, along with the expression of several non-coding microRNAs (miR-150, miR-146a, miR-181a, and miR-223) in jSpA patients. Peripheral blood samples were obtained from 19 patients newly diagnosed with jSpA according to ILAR classification criteria for enthesitis-related arthritis (ErA) and seven gender-and age-matched subjects without any symptoms or signs of inflammatory disease. The expression of specific microRNAs was analyzed using qRT-PCR with predeveloped microRNA assays. DNA promoter region methylation status of selected genes was assessed by methylated DNA immunoprecipitation (MeDIP) analysis. Fold enrichment of immunoprecipitated DNA differed significantly for NLRP3 promoter site, while the expression analysis of selected microRNAs showed no significant difference in fold change between jSpA patients and healthy controls. The results indicated that epigenetic modifications in the initial phase of the disease could be responsible for some of the expression alterations in jSpA patients. Since NLRP3 has a crucial role in inflammasome assembly and inflammasomes have been shown to shape microbiota, it is tempting to assume that dysbiosis in jSpA patients can at least partially be explained by reduced NLRP3 expression due to hypermethylation, stressing for the first time the epigenetic contribution to jSpA pathophysiology.
Introduction
Juvenile spondyloarthritis (jSpA) is a diverse group of related seronegative inflammatory disorders with shared symptoms that affect children and adolescents younger than 16 years of age and often remains active during adulthood [1] . Despite some differences in disease presentation between children and adults, mostly in the tendency to involve axial joints which is more remarkable in adults, there are emerging views that spondyloarthritis (SpA) surpasses this arbitrary age-based divide [2] . The crucial features of SpA include enthesitis and/ or arthritis of both peripheral and axial joints, characterized by bone erosions and reactive new bone formation. Besides the bones, inflammatory lesions can be found in the colon, skin, and eye, leading to (sub) clinical gut inflammation, psoriasis, and acute anterior uveitis, respectively [3] . Based on resulting clinical symptoms jSpA can be divided into differentiated forms like juvenile ankylosing spondylitis (jAS), psoriatic arthritis (PsA), reactive arthritis (ReA) and arthritis associated with inflammatory bowel disease, and undifferentiated forms like seronegative enthesopathy and arthropathy syndrome (SEA) and enthesitis-related arthritis (ErA) [4] . These various clinical forms are, however, marked by shared pathogenic mechanisms in which both environmental factors and genetic background perpetuate inflammatory response through meticulous immune system alterations. Although most of the genetic influence in jSpA is attributable to one family of major histocompatibility complex (MHC) class I alleles, HLA-B27, which accounts for up to 25% of known heritability in AS, the precise molecular mechanisms explaining this association are still ambiguous [5, 6] . Recent genome-wide association studies (GWAS) have further implicated the role of non-MHC genes, including the endoplasmic reticulum aminopeptidase 1 (ERAP1), in the development of AS via their interaction with HLA-B27 [6] . Nonetheless, to understand the disease mechanism and close the gap between genotype and phenotype, other genomic data, such as quantification of gene expression, are required. To date, several expression profiling studies in patients diagnosed with SpA have been conducted, with the majority focused on AS patients, and only a few involving jSpA patients [7] [8] [9] . Hence, our group recently performed a thorough gene expression analysis in a very homogenous group of jSpA patients diagnosed according to ILAR classification criteria for ErA [10] . The results of the study revealed increased expression of TLR4 and CXCR4, with decreased expression of NLRP3 and PTPN12 genes. Although these findings provided a better insight into the disease pathology, the processes behind the observed alterations remained unknown.
As an intermediary between environmental factors and gene expression, epigenetic mechanisms are implicated in the pathogenesis of numerous rheumatic diseases in adults [11] . More recently, epigenetic variations have also been associated with juvenile idiopathic arthritis (JIA), although to a lesser relevance than in adults [12] . In their basis, epigenetic alterations are defined as heritable changes that do not involve alterations in the DNA sequence, but processes such as DNA methylation, histone modification, and non-coding RNA (ncRNA)-associated gene silencing [13] . DNA methylation adds methyl (CH 3 ) group to the 5-carbon of the cytosine ring, which can result in transcriptional gene repression when occurring in the promoter region [14, 15] . This process is mediated by the family of DNA methyltransferases (DNMT), a conserved set of DNA-modifying enzymes which have become increasingly popular as a new target for drugs with epigenetic modes of action, so-called epidrugs [16] . As opposite, microRNAs (miRs) regulate expression by translational repression or mRNA degradation. Those short (19-23 nucleotides), non-coding small regulatory RNAs are loaded into the RNA-induced silencing complex, where they recognize typically the 3′-untranslated region (UTR) of target genes [17, 18] .
The aims of this study were to evaluate the methylation levels of the TLR4, CXCR4, NLRP3, and PTPN12 gene promoter and the expression of several non-coding microRNAs (miR-150, miR-146a, miR-181a, and miR-223) in the jSpA patients.
Materials and Methods

Patients
Peripheral blood samples were obtained at the Division of Clinical Immunology and Rheumatology at the Department of Pediatrics in Sestre milosrdnice University Hospital Center, Zagreb, Croatia, from 19 consecutive patients diagnosed with jSpA according to ILAR classification criteria for ErA [19] . The median age of those patients was 15 years (IQR 12.9-16 years). None of them had disease symptoms for more than 6 months and none received any disease-modifying antirheumatic drug (DMARD). Further on, none of the patients had any signs or symptoms of inflammatory bowel disease or uveitis. Ten of the patients were positive for B27 antigen (52.6%), while basic immunological tests (ANA, RF) were negative in all of the patients. Blood samples from seven gender-and agematched children with no signs or symptoms of any acute or chronic disease were collected during their follow-up visit to one of the Outpatient Clinics at the Department of Pediatrics in Sestre milosrdnice University Hospital Center, Zagreb, Croatia. Patient characteristics, treatment at the time of sampling, and performed analysis are shown in Table 1 .
Methylated DNA Immunoprecipitation (MeDIP) Analysis
MeDIP (methylated DNA immunoprecipitation) was performed using the MagMeDIP kit (mc-magme-048, Diagenode) according to the manufacturer's protocol in all study subjects. In brief, 30 μg DNA isolated from peripheral blood mononuclear cells was sonicated with the Bioruptor sonicator (Diagenode) to 100-to 600-bp fragments. Sonicated DNA was denatured for 5 min at 95°C, and quickly chilled on ice. At this point around 10% of each sample was saved as a control of starting material. The rest was immunoprecipitated with 5-methylcytosine antibody overnight at 4°C in the presence of magnetic beads at rotating wheel. Magnetic beads with immunoprecipitated DNA were washed three times. Enrichment in MeDIP fraction was determined by quantitative real-time PCR using AriaMx (Agilent). For all genes examined (TLR4, NLRP3, CXCR4, and PTPN12), primers were obtained for the amplification of promoter regions (Table 2) . MeDIP results were expressed as fold enrichment of immunoprecipitated DNA for each site. Fold enrichment was calculated by the 2 -ΔΔCt method, in which Ct indicates cycle threshold at which the fluorescence level reaches detection threshold. The ΔCT is the difference in threshold cycle between the target and the housekeeping gene myoglobin.
MicroRNA Expression Analysis
Whole RNA was extracted from whole blood using the PAXgene Blood RNA Kit (Qiagen) in eight jSpA and five control subjects. Reverse transcription was performed using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and microRNAs specific primers according to manufacturer's protocol. Specific microRNA expression was analyzed using real-time PCR with predeveloped microRNA assays: miR-146a (assay ID 002163), miR-150 (assay ID 000473), miR-181a (assay ID 000480), and miR-223 (assay ID 002295) (Applied Biosystems). The results were normalized using RNU48 as endogenous control (Applied Biosystems). Relative microRNAs expressions were calculated by the 2 −ΔΔCt method, in which Ct indicates cycle threshold, the fractional cycle number where the fluorescent signal reaches detection threshold. The fold change was computed using the average difference in Ct values between a specific microRNA and internal control β-actin.
Statistical Analysis
Statistical analysis was performed using GraphPad version 6.01 for Windows, GraphPad Software, La Jolla, CA, USA, www.graphpad.com. The data did not meet the normality assumption; therefore, the results were described as median with interquartile range (IQR). Mann-Whitney U test was applied for microRNA expression and MeDIP analysis. The statistical significance level was set to 0.05.
Results
Methylated DNA Immunoprecipitation Analysis
The median fold enrichment (FD) of immunoprecipitated DNA for TLR4 promoter site was 0.10 and 0.17 in jSpA and healthy control participants, respectively. For NLRP3 promoter site, the median fold enrichment was 9.29 in jSpA patients and 3.83 in matched control group. Further on, for CXCR4 promoter site, the median fold enrichment was 0.21 in jSpA group and 0.10 in control group. Finally, the median fold enrichment of immunoprecipitated DNA for PTPN12 gene promoter site was 0.29 in jSpA patients and 0.22 in healthy controls. The difference in fold enrichment of immunoprecipitated DNA between jSpA patients and healthy subjects was statistically significant only for NLRP3 promoter site (p = 0.0004). The results of methylated DNA immunoprecipitation (MeDIP) analysis are presented in Fig. 1 .
MicroRNA Expression Analysis
The results for expression analysis of all four selected miRs (miR-150, miR-146a, miR-181a, and miR-223) showed no statistically significant difference in fold change between two groups (jSpA patients and healthy controls). The results are shown in Fig. 2 . Fig. 2 Results of expression analysis for miR-150, miR-146a, miR-181a, and miR-223. Fold change (FC) represents the relative increase (+) or decrease (−) of expression calculated using the 2-ΔΔCt method and p stands for the calculated p value. The lines represent median values and whiskers the IQR values for each group, respectively. P < 0.05 was considered significant
Discussion
Our previous study demonstrated that jSpA patients exhibit complex patterns of gene expression for functions related to inflammatory and defense response, mitogen-activated protein (MAP) kinase and cell cycle, chromatin modulation and transcription, cell death, and apoptosis [10] . NLRP3, a gene closely linked to autoinflammatory diseases was among genes with consistently decreased expression, while TLR4, another gene important for inflammatory response, had persistently increased expression in jSpA patients. In the present study, we showed that NLRP3 gene promoter site is significantly more methylated in the newly diagnosed jSpA patients, which can be responsible for previously observed expression alteration. While increased expression of the NLRP3 gene has been found in many autoinflammatory diseases, decreased expression has been associated with inflammatory bowel disease (IBD), a disease that shares some striking similarities with jSpA, including the gut dysbiosis [20, 21] . The NLRP3 gene has a crucial role in the assembly of the NLRP3 inflammasome, an innate immune sensor that regulates Bdanger^in response to various signals [22] . Due to an important task in the maintenance of intestinal homeostasis through the regulation of the innate immune system and expression of colonic β-defensins, the NLRP3 inflammasome must be tightly controlled [23] . The absence of NLRP3 signaling (with concomitantly decreased IL-1β) results in the alteration of gut microbiota composition in mouse models, with increased intestinal colonization of pathogenic species [24] . The great number of evidences, both from animal and human studies, indicates that any modification of the gut microbiota can lead to dysbiosis and development of various immune-mediated inflammatory diseases [25] . While further studies are needed in order to elucidate if observed epigenetic alterations in jSpA patients are caused by genetic mutations in epigenetic factors leading to reduced NLRP3 expression, inflammasome malfunction and dysbiosis or dysbiosis resulting from various and largely unknown environmental factors influences gene expression through epigenetic modifications, it is tempting to assume that reduced NLRP3 expression due to hypermethylation is at least partially responsible for distinctive microbiota composition and creation of a disease-permissive milieu in jSpA patients (Fig. 3) . This link might not be important just for the improved understanding of the molecular mechanism underlying the disease development but could also have meaningful repercussions for the predicament of the disease outcome and treatment response, since a correlation between specific epigenetic signatures and severity has been described in several diseases [26] . Finally, the reversible nature of epigenetic mechanisms makes them an attractive therapeutic target with several drugs already approved for the treatment of various inflammatory rheumatic diseases [27] .
The four microRNAs tested in the present study (miR-150, miR-146a, miR-181a, and miR-223) were prudently selected based on previously reported interactions with NLRP3, TLR4, PTPN12, or CXCR4 gene [28] [29] [30] [31] [32] [33] [34] . However, the lack of the expression alterations does not exclude the possible role of this or other microRNAs in post-transcriptional regulation of the selected genes but warrants additional studies.
Conclusion
Well aware of many limitations of presented study, including small number of patients, lack of analysis in more specific cell population and absence of confirmatory methods, we believe that observed DNA methylation-based signature of the NLRP3 gene brings unprecedented data that could have important implications in addressing environmental and genetic contribution to the development of jSpA.
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